29th-Jan-2023 15:35Source: BSE

Suven Pharmaceuticals - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in terms of SEBI Circular No. SEBIIHO/MIRSD/MIRSD_RTAMB/P/CIR /2022/8 dated January 25, 2022, this is to inform you that the Company has received intimation from our RTA dated January 27, 2023 regarding issued a 'Letter of Confirmation' in lieu of share certificate(s) reported as lost/misplaced by the following shareholders(s).